FDA approves Exactech’s new Gibralt Occipital Spine System
The US Food and Drug Administration (FDA) has accorded its approval for a new Gibralt Occipital Spine System, developed by the US-based Exactech. The clearance is expected to allow the company to proceed with its plans to make initial launch of the complete Gibralt system in the US market. The addition of the new device…